Galapagos NV
GLPG
$29.08
Share price
0.59%
Change (1 day)
-22.31%
Change (1 year)
Categories
Earnings for Galapagos NV (GLPG)
Earnings in 2023 (TTM): $4.25 M
According to Galapagos NV's latest financial reports the company's current earnings (TTM) are $4.25 M. In 2022 the company made an earning of -$0.24 B a decrease over its 2021 earnings that were of -$0.15 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Galapagos NV from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $4.25 M | -101.83% |
| 2022 | -$0.24 B | 59.92% |
| 2021 | -$0.15 B | -59.99% |
| 2020 | -$0.37 B | -329.45% |
| 2019 | $0.15 B | -528.39% |
| 2018 | -$36.95 M | -72.46% |
| 2017 | -$0.14 B | -330.83% |
| 2016 | $58.11 M | -144% |
| 2015 | -$0.14 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | 398,743.79% | 🇺🇸 USA |
 Abbott Laboratories ABT | $6.66 B | 156,504.70% | 🇺🇸 USA |
 AbbVie ABBV | $6.25 B | 146,775.66% | 🇺🇸 USA |
 Sanofi SNY | $8.39 B | 197,191.38% | 🇫🇷 France |
 Merck MRK | $3.03 B | 71,222.82% | 🇺🇸 USA |
 AstraZeneca AZN | $8.49 B | 199,533.40% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $7.53 B | 176,973.77% | 🇬🇧 UK |
 Fortress Biotech
FBIO | -$0.16 B | -3,710.42% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $0.40 B | 9,417.54% | 🇮🇱 Israel |